3 Reasons Canopy Growth (TSX:WEED) Stock Is Worth Buying

Canopy Growth (TSX:WEED)(NYSE:CGC) is increasingly looking like a reasonable investment for long-term contrarians willing to take the risk.

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It isn’t easy taking a contrarian stance on an industry that’s been at the centre of the investment community’s attention for the past few years. However, I believe all investors should play devil’s advocate to seek out the best opportunities. 

And Canada’s legal pot sector seems to be screaming out for advocacy at the moment. A wave of legal issues, distribution bottlenecks, regulatory hurdles, lack of cash flow, and shift in sentiment has wiped out nearly half the value of the largest players and pushed smaller ones to the verge of potential bankruptcy. 

Industry leader Canopy Growth (TSX:WEED)(NYSE:CGC) is probably the best example. The stock has lost nearly two-thirds of its value over the past five months or so. With its founder gone and sales coming in lower than expected, things just seem to be getting worse. 

But that doesn’t mean the firm is doomed or worth ignoring. Here are three reasons investors should consider buying, or at least monitoring, the stock over the next few quarters.

Cash

When drinks giant Constellation Brands purchased a hefty chunk of Canopy, it injected $5 billion into the company. Nearly a year later, that cash hoard is down to just $3.8 billion. 

However, that’s still plenty of cash to help the company finance itself for the next two years or so, which means it could bootstrap its way to operational profitability. Meanwhile, the stock trades at 2.3 times cash per share and 1.8 times book value per share. That seems bizarrely low for a company projecting double-digit sales growth going forward. 

New management

Canopy’s notorious founder and leader Bruce Linton was ousted earlier this year, and his replacement hasn’t been picked yet. However, Constellation has installed its chief financial officer David Klein as chairman of the board and Mike Lee as chief financial officer, indicating that financial discipline and better allocation of cash is probably the company’s top priority at this moment. 

I would expect the next CEO to picked in the same vein — focused on “paving a clear path to profitability,” as management said on a recent call with analysts.  

Double-digit growth for a decade

Meanwhile, the global market for legal cannabis continues to mature. Frameworks for legal sales are being installed in several countries, ranging from Thailand to Columbia. By 2025, the legal weed market is expected to reach US$66 billion in sales, implying a double-digit annual growth factor.

Meanwhile, the combined value of Canada’s four largest cannabis companies has shrunk to roughly $20 billion (US$15 billion) at the time of writing. It may be fair to assume that one of these top producers will dominate the global industry once the market matures and stabilizes. In my view, Canopy is well positioned for that. 

Bottom line

As investor sentiment goes from irrational exuberance to serious pessimism, the valuations of these pot stocks are finally getting reasonable. With enough cash to survive for years and new management, Canopy Growth is increasingly looking like a reasonable investment for long-term contrarians willing to take the risk.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »